CBD Life Sciences Inc. (CBDL) Huge Momentum Following NECANN New Jersey 2025
CBD Life Sciences Inc. (OTC:CBDL) reports significant momentum following its participation at NECANN New Jersey 2025, one of the largest cannabis trade shows in the country. The company has entered into advanced negotiations with five major dispensaries across Pennsylvania & New Jersey, potentially accessing thousands of retail customers.
CBDL is also expanding its beverage portfolio, with CBD Seltzer and CBD Lemonade Drink planned for distribution in sports stadiums. The U.S. marijuana dispensary market is projected to reach $31.8 billion annually by 2025, with CBD-infused beverages showing a CAGR exceeding 20%. The company's dual strategy focuses on dispensary expansion and mass-market beverage distribution in sports venues.
CBD Life Sciences Inc. (OTC:CBDL) riferisce un notevole slancio dopo la partecipazione a NECANN New Jersey 2025, una delle fiere della cannabis più grandi del paese. L'azienda è entrata in avanzate trattative con cinque importanti dispensari in Pennsylvania e New Jersey, con potenziale accesso a migliaia di clienti al dettaglio. CBDL sta inoltre espandendo il suo portafoglio di bevande, con CBD Seltzer e CBD Lemonade Drink previsti per la distribuzione negli stadi sportivi. Il mercato statunitense delle dispensarie di marijuana è previsto raggiungere $31,8 miliardi all'anno entro il 2025, con le bevande a base CBD che mostrano una CAGR superiore al 20%. La strategia duale dell'azienda si concentra sull'espansione delle dispensarie e sulla distribuzione di bevande su larga scala nelle sedi sportive.
CBD Life Sciences Inc. (OTC:CBDL) informa de un impulso significativo tras su participación en NECANN New Jersey 2025, una de las ferias de cannabis más grandes del país. La compañía ha entrado en negociaciones avanzadas con cinco importantes dispensarios en Pensilvania y Nueva Jersey, lo que podría permitir acceso a miles de clientes minoristas. CBDL también está ampliando su cartera de bebidas, con CBD Seltzer y CBD Lemonade Drink previstos para su distribución en estadios deportivos. Se proyecta que el mercado minorista de dispensarios de marihuana en Estados Unidos alcance 31,8 mil millones de dólares anuales para 2025, con bebidas infundidas con CBD mostrando un CAGR superior al 20%. La estrategia dual de la empresa se centra en la expansión de dispensarios y la distribución de bebidas de gran difusión en venues deportivos.
CBD Life Sciences Inc. (OTC:CBDL)은 NECANN 뉴저지 2025 참가 이후 상당한 모멘텀을 보고하며, 전국에서 가장 큰 대마초 무역 박람회 중 하나입니다. 회사는 펜실베이니아와 뉴저지 전역의 다섯 대형 디스펜서와의 고급 협상에 진입했고, 수천 명의 소매 고객에 접근할 수 있을 가능성이 있습니다. CBDL은 음료 포트폴리오도 확장하고 있으며, CBD Seltzer와 CBD Lemonade Drink가 스포츠 경기장에 유통될 예정입니다. 미국 대마 디스펜서 시장은 2025년까지 연간 $31.8억 달러에 이를 것으로 전망되며, CBD 함유 음료는 연평균 성장률(CAGR)이 20%를 상회하는 것으로 보입니다. 회사의 이중 전략은 디스펜서 확장과 스포츠 경기장에서의 대규모 음료 유통에 중점을 둡니다.
CBD Life Sciences Inc. (OTC:CBDL) annonce un élan significatif après sa participation au NECANN New Jersey 2025, l’un des plus grands salons de cannabis du pays. La société est entrée en négociations avancées avec cinq grands dispensaires dans l’ensemble de la Pennsylvanie et du New Jersey, ce qui pourrait donner accès à des milliers de clients au détail. CBDL élargit également son portefeuille de boissons, avec CBD Seltzer et CBD Lemonade Drink prévus pour être distribués dans les stades sportifs. Le marché américain des dispensaires de marijuana devrait atteindre 31,8 milliards de dollars annuels d’ici 2025, les boissons infusées au CBD affichant une croissance annuelle composée (CAGR) supérieure à 20 %. La stratégie double de l’entreprise se concentre sur l’expansion des dispensaires et la distribution de boissons grand public dans les sites sportifs.
CBD Life Sciences Inc. (OTC:CBDL) meldet signifikantes Momentum nach seiner Teilnahme an NECANN New Jersey 2025, einer der größten Cannabis-Messen des Landes. Das Unternehmen hat fortgeschrittene Verhandlungen mit fünf großen Dispensaries in Pennsylvania & New Jersey aufgenommen, was potenziell Tausende von Einzelhandelskunden eröffnet. CBDL erweitert auch sein Getränkeportfolio, mit CBD Seltzer und CBD Lemonade Drink, die voraussichtlich in Sportstadien verteilt werden. Der US-Dispenser-Markt für Marihuana wird voraussichtlich bis 2025 jährlich 31,8 Milliarden US-Dollar erreichen, wobei CBD-infundierte Getränke eine CAGR von über 20 % zeigen. Die Doppelstrategie des Unternehmens konzentriert sich auf die Expansion von Dispensaries und den Massenmarkt-Vertrieb von Getränken in Sportstätten.
CBD Life Sciences Inc. (OTC:CBDL) تعلن عن زخم ملحوظ عقب مشاركتها في NECANN نيوجيرسي 2025، أحد أكبر معارض القنب في البلاد. دخلت الشركة في مفاوضات متقدمة مع خمس صيدليات توزيع رئيسية عبر بنسلفانيا ونيوجيرسي، مما قد يتيح الوصول إلى آلاف عملاء التجزئة. كما توسع CBDL محفظة مشروباته، مع مشروب CBD Seltzer وCBD Lemonade Drink المقرر توزيعه في الاستادات الرياضية. من المتوقع أن يصل سوق صيدليات الماريجوانا الأمريكية إلى 31.8 مليار دولار سنوياً بحلول 2025، مع نمو مشروبات CBD المعززة بنمو سنوي مركب يتجاوز 20%. استراتيجيت الشركة المزدوجة تركز على توسيع الصيدليات وتوزيع المشروبات على نطاق واسع في أماكن الرياضة.
CBD Life Sciences Inc.（OTC:CBDL） 在参加 NECANN New Jersey 2025 后宣布取得显著进展，这是全美最大的大麻贸易展之一。公司已与宾夕法尼亚州和新泽西州的五家主要药房进入高级谈判，可能让其获得数千名零售客户。CBDL 也在扩展其饮料产品组合，CBD Seltzer 和 CBD Lemonade Drink 计划在体育场馆分销。美国大麻药房市场预计到 2025 年将达到 $31.8 十亿美元/年，CBD infused 饮料的年复合增长率（CAGR）超过 20%。公司的双轨策略专注于药房扩张和在体育场馆的大众市场饮料分销。
- Advanced negotiations with 5 major dispensaries in Pennsylvania & New Jersey
- Planned distribution of CBD beverages in sports stadiums with exposure to millions of consumers
- Operating in a market projected to reach $31.8B by 2025
- CBD beverage category growing at over 20% CAGR
- Letters of Intent (LOIs) are not yet finalized into binding contracts
- Revenue impact from new initiatives remains uncertain
- Operating in a highly competitive and regulated cannabis market
The U.S. marijuana dispensary market is projected to generate over
SCOTTSDALE, ARIZONA / ACCESS Newswire / September 16, 2025 / CBD Life Sciences Inc. (OTC:CBDL), the parent company of The CBD Vault, is proud to announce significant progress following its recent participation at the NECANN New Jersey 2025 Cannabis Conference, one of the largest cannabis trade shows in the country. This high-visibility event has positioned CBDL at the forefront of the industry, paving the way for Letters of Intent (LOIs) and advanced negotiations with five major dispensaries across Pennsylvania & New Jersey.
These five dispensaries collectively represent access to thousands of retail customers and the potential for multi-million-dollar annual revenue contributions once contracts are finalized. By strategically aligning with dispensary operators who have strong market penetration and loyal customer bases, CBDL expects to accelerate its revenue growth trajectory while cementing itself as a recognized provider of premium CBD wellness products.
Beyond dispensaries, CBDL is actively advancing its proprietary beverage portfolio. The CBD Vault's CBD Seltzer and CBD Lemonade Drink are already generating strong interest and are slated for distribution in football and baseball stadiums. With sports venues averaging tens of thousands of attendees per game, these distribution channels are poised to expose CBDL's brand to millions of consumers annually. The ability to penetrate this mainstream market represents a transformational growth catalyst, bridging the gap between the cannabis sector and traditional consumer packaged goods.
Why NECANN Matters for CBDL:
NECANN is one of the nation's most respected cannabis conferences, drawing investors, dispensary owners, and operators from across the U.S.
The event gave CBDL the opportunity to showcase its full product suite, including topicals, tinctures, edibles, and beverages, while networking directly with decision-makers.
Unlike smaller trade shows, NECANN provides the credibility and scale needed to attract institutional-level buyers and partners.
The Cannabis Market Outlook:
According to BDSA, legal cannabis dispensaries in the U.S. are on track to generate over
$31.8 billion in revenue by 2025.CBD-infused beverages are projected to be one of the fastest-growing categories in the industry, with estimates showing a compound annual growth rate (CAGR) exceeding
20% .By securing both dispensary shelf space and stadium distribution, CBDL is positioned to capture value across multiple billion-dollar verticals simultaneously.
"Our NECANN New Jersey experience was more than just networking - it was a launching pad," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "The five dispensaries we are now engaged with each have the ability to add meaningful revenue to our bottom line. At the same time, our CBD seltzer and lemonade beverages are gaining traction with stadium operators, creating one of the most exciting growth opportunities our company has ever seen. We believe this dual approach - dispensary expansion and mass-market beverage distribution - sets CBDL apart as a true leader in the space."
For shareholders, these developments underscore CBDL's scalable growth model. By diversifying distribution between regulated cannabis channels and mainstream consumer venues, the Company is uniquely positioned to benefit from both the rapid expansion of legal cannabis and the surging demand for functional wellness beverages.
CBD Life Sciences Inc. will continue to update investors as agreements with dispensaries are finalized and beverage rollouts progress. Additional announcements are expected in the coming weeks as the Company executes its aggressive expansion strategy.
About CBD Life Sciences Inc. (CBDL):
CBD Life Sciences Inc. is a publicly traded company (OTC:CBDL) operating as The CBD Vault, offering a full line of cannabidiol-based products including tinctures, edibles, topicals, beverages, and more. With a focus on innovation, high-quality ingredients, and strategic partnerships, the Company is rapidly expanding its footprint across retail, dispensary, and direct-to-consumer channels.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
New Website Under Construction https://www.thecbdvault.com
IR Contact: cbdvaultaz@gmail.com
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
SOURCE: CBD Life Sciences, Inc.
View the original press release on ACCESS Newswire
FAQ
What major announcements did CBD Life Sciences (CBDL) make at NECANN New Jersey 2025?
How many dispensaries is CBDL negotiating with after NECANN 2025?
What is the projected size of the U.S. marijuana dispensary market by 2025?
What new products is CBDL planning to distribute in sports venues?
What is the growth rate of CBD-infused beverages according to CBDL?
